Cargando…

A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine

Myocarditis and/or pericarditis have been reported as adverse events following coronavirus disease 2019 (COVID-19) messenger RNA vaccination, with most cases occurring within 1 week after the second dose. We report a rare case of myocarditis after the first dose of the BNT162b2 (Pfizer-BioNTech) COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Seunghwan, You, Jihye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039195/
https://www.ncbi.nlm.nih.gov/pubmed/35470603
http://dx.doi.org/10.3346/jkms.2022.37.e131
_version_ 1784694071347904512
author Park, Seunghwan
You, Jihye
author_facet Park, Seunghwan
You, Jihye
author_sort Park, Seunghwan
collection PubMed
description Myocarditis and/or pericarditis have been reported as adverse events following coronavirus disease 2019 (COVID-19) messenger RNA vaccination, with most cases occurring within 1 week after the second dose. We report a rare case of myocarditis after the first dose of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine in a 17-year-old boy. Here, we describe the laboratory, electrocardiographic, and imaging findings of myocarditis.
format Online
Article
Text
id pubmed-9039195
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-90391952022-05-05 A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine Park, Seunghwan You, Jihye J Korean Med Sci Case Report Myocarditis and/or pericarditis have been reported as adverse events following coronavirus disease 2019 (COVID-19) messenger RNA vaccination, with most cases occurring within 1 week after the second dose. We report a rare case of myocarditis after the first dose of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine in a 17-year-old boy. Here, we describe the laboratory, electrocardiographic, and imaging findings of myocarditis. The Korean Academy of Medical Sciences 2022-04-20 /pmc/articles/PMC9039195/ /pubmed/35470603 http://dx.doi.org/10.3346/jkms.2022.37.e131 Text en © 2022 The Korean Academy of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Park, Seunghwan
You, Jihye
A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine
title A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine
title_full A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine
title_fullStr A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine
title_full_unstemmed A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine
title_short A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine
title_sort case of myocarditis presenting with a hyperechoic nodule after the first dose of covid-19 mrna vaccine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039195/
https://www.ncbi.nlm.nih.gov/pubmed/35470603
http://dx.doi.org/10.3346/jkms.2022.37.e131
work_keys_str_mv AT parkseunghwan acaseofmyocarditispresentingwithahyperechoicnoduleafterthefirstdoseofcovid19mrnavaccine
AT youjihye acaseofmyocarditispresentingwithahyperechoicnoduleafterthefirstdoseofcovid19mrnavaccine
AT parkseunghwan caseofmyocarditispresentingwithahyperechoicnoduleafterthefirstdoseofcovid19mrnavaccine
AT youjihye caseofmyocarditispresentingwithahyperechoicnoduleafterthefirstdoseofcovid19mrnavaccine